Key result
Blood fibrosis biomarkers reflect extracellular matrix changes and myocardial remodeling in arterial hypertension.
This review highlights the potential of circulating biomarkers to assess myocardial fibrosis and remodeling in patients with arterial hypertension.
Answers are grounded in this paper and cite their sources.
May support noninvasive fibrosis monitoring in hypertension; hypothesis-generating, needs prospective validation before practice change.
The article presents a review of the literature on the role of myocardial fibrosis in the development of myocardial remodeling in patients with arterial hypertension. Information about the state of the structure and function of the extracellular matrix in health and disease is generalized. The characteristics of myocardial fibrosis biomarkers detection in the circulating blood are reflected.
No takes yet. Share an insight, caveat, or question.
Dotsenko et al. (2020) studied this question. Circulating blood biomarkers of myocardial fibrosis reflect extracellular matrix changes and the development of myocardial remodeling in patients with arterial hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: